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Increased generation of reactive oxygen species (ROS) leads
to oxidative stress in diabetes. Catalase is a highly conserved
heme-containing protein that reduces hydrogen peroxide to
water and oxygen and is an important factor decreasing
cellular injury owing to oxidative stress. Hyperglycemic
conditions increase oxidative stress and angiotensinogen
gene expression. Angiotensinogen conversion to angiotensin
II leads to a furtherance in oxidative stress through increased
generation of reactive oxygen species. In this study, we
utilized mice transgenically overexpressing rat catalase in a
kidney-specific manner to determine the impact on ROS,
angiotensinogen and apoptotic gene expression in proximal
tubule cells of diabetic animals. Proximal tubules isolated
from wild-type and transgenic animals without or with
streptozotocin-induced diabetes were incubated in low
glucose media in the absence or presence of angiotensin II or
in a high-glucose media. Our results show that the
overexpression of catalase prevents the stimulation of ROS
and angiotensinogen mRNA in tubules owing to elevated
glucose or angiotensin II in vitro. Additionally, overexpression
of catalase attenuated ROS generation, angiotensinogen and
proapoptotic gene expression and apoptosis in the kidneys
of diabetic mice in vivo. Our studies point to an important
role of ROS in the pathophysiology of diabetic nephropathy.
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Oxidative stress is defined as tissue injury induced by
increased reactive oxygen species (ROS) generation. The
key initial step in ROS formation is the conversion of
molecular oxygen (O2) to superoxide (O2
K). Several
enzymatic pathways can generate O2
K, but in quantitative
terms, the electron transport chain in mitochondria and
nicotinamide-adenine dinucleotide phosphate (NADPH)
oxidase in membrane are the most important sources in
both physiological and pathological conditions (reviewed in
references1–5). Superoxide dismutases are key enzymes that
neutralize O2
K into less reactive hydrogen peroxide (H2O2)
which is then reduced to H2O by catalase (CAT) or
glutathione peroxidase.
Mammalian CAT is a tetrameric 240-kDa heme-contain-
ing protein that is highly conserved in humans, rats, and
mice.6–8 CAT expression is highly tissue-specific with the
highest levels being found in the liver, kidney, and blood.9–11
In the kidney, CAT is localized predominantly in the
cytoplasm of proximal tubules of the juxtamedullary cortex,
with a lesser amount in proximal tubules of the superficial
cortex. It is not detected in the glomeruli, distal tubules, loop
of Henle, and collecting ducts.12
The role of CAT in defending against cell and tissue injury
by oxidative stress has been studied extensively. CAT
overexpression renders cells more resistant to H2O2 toxicity
and oxidant-mediated injury.13,14 Transgenic (Tg) mice
overexpressing CAT are protected against myocardial injury
in hypertension.15,16 In contrast, CAT knockout or null mice
are phenotypically normal,17 without those clinical manifes-
tations of acatalasemia as seen in humans including oral
ulcers and periodic hemolytic episodes.18 However, CAT-null
mice show differential sensitivity to oxidant-mediated tissue
injury.17 H2O2 is also known to control cell proliferation via
modulation of cell signalling.19 It is postulated that CAT
overexpression might modulate H2O2 levels and thereby alter
specific gene expression and cellular function in a tissue-
specific manner.
Glomerular damage is a hallmark of renal injury in
diabetes.20 However, a number of studies reported that
tubular atrophy might be a better predictor of renal disease
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progression than glomerular pathology.21–23 Both tubular
atrophy and interstitial fibrosis are closely associated with
loss of renal function.24,25 Furthermore, 71% of glomeruli
from proteinuric type I diabetic patients have glomerulo-
tubular junction abnormalities, including 8–17% atubular
glomeruli,26,27 indicating that proximal tubular atrophy
contributes significantly to renal failure in diabetes.
The mechanisms underlying tubular atrophy are not well
understood. One attractive mechanism is apoptosis, which
has been demonstrated to mediate cell death in a variety of
renal diseases including diabetes.28–33 We reported previously
that high glucose evokes ROS generation and enhances
angiotensinogen (Agt, the sole substrate of the renin-
angiotensin system (RAS)) gene expression in rat renal
proximal tubular cells (RPTCs).34,35 The objective of this
study was to define whether overexpressing CAT in RPTCs
could attenuate ROS generation by high glucose and Ang II
that lead to increased Agt and proapoptotic gene expression
as well as to the induction of RPTC apoptosis in diabetic
mice in vivo. For this purpose, we generated Tg mice
overexpressing rat CAT (rCAT) in their RPTCs using the
kidney-specific androgen-regulated protein (KAP)-gene pro-
moter linked to rCAT cDNA. This promoter targets the gene
of interest to proximal tubules, where the transgene will
respond to androgen.36
RESULTS
Tissue-specific expression of the KAP2-rCAT transgene
in Tg mice
Tg mice were generated to produce specific and inducible
expression of rCAT in RPTCs using KAP2-rCAT construct
(Figure 1a). Southern blot analysis confirmed the presence of
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Figure 1 | Generation of Tg mice. (a) Schematic map of the KAP2rCAT construct. The rCAT cDNA fused with HA-tag was inserted into the NotI
sites in exon II of human Agt gene. The transgene was excised as a SpeI and NdeI fragment for microinjection. (b) Southern blot analysis
of tail biopsies of founders, F1, F2, and F3 generations of Tg mice. Extracted genomic DNA was digested with BamHI and migrated onto 0.8%
agarose gel. The positive control (þ ) is composed of 10 pg of rCAT cDNA insert mixed with 10 mg of WT BamHI-digested genomic DNA.
(c) Southern blot of RT-PCR product showing tissue expression of rCAT-HA mRNA in male uninduced or induced with testosterone Tg mice. rCAT
and b-actin fragments are indicated. Male (line no.; 688) mice were induced with placebo or testosterone for 2 weeks before RNA isolation. L,
liver; S, spleen; Lu, lung; H, heart; K, kidney; Br, brain; T, testes. (d) Western blot analysis of rCAT expression in mouse RPT extracts of male WT and
Tg mice (line no.;688). (e) CAT activity in mouse RPT extracts of female Tg mice with or without testosterone (Testo) induction and male (M) WT
and Tg mice. CAT activity is defined as mmol of H2O2 consumed/min/mg of tissue protein at 10 mM H2O2 (*Po0.05, **Po0.01, ***Po0.005).
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the transgene in heterozygote and homozygote animals
(Figure 1b). Figure 1c displays the specific reverse transcriptase-
polymerase chain reaction (RT-PCR) analysis of rCAT-HA
transgene expression in various tissues of Tg line 688. Male Tg
mice express the transgene in the kidney but not in other
tissues, and exogenous testosterone further enhances renal
transgene expression.
An increase in CAT protein and CAT activity in the renal
proximal tubules (RPTs) of male Tg mice without exogenous
testosterone induction was also apparent in comparison with
male wild type (WT) mice (Figure 1d and e). Testosterone
administration evoked a three-fold increase in CAT activity in
RPTs in female Tg mice (Figure 1e). Taken together, these
results confirm that KAP2 directs rCAT transgene expression
in RPTs of Tg mice. Thus, in subsequent experiments, we
used male Tg mice without exogenous testosterone induc-
tion, as endogenous testosterone was sufficient to stimulate
rCAT expression and activity in RPTs.
rCAT overexpression inhibits RPT ROS generation and ANG
gene expression ex vivo
To demonstrate rCAT transgene functionality, freshly isolated
RPTs were incubated ex vivo for 5 h in normal glucose
medium (5 mM D-glucose plus 20 mM D-mannitol) in the
absence or presence of Ang II (109 mM) or in high glucose
medium (25 mM D-glucose). ROS generation was augmented
in RPTs of WT mice incubated in normal glucose medium
plus (Ang II) or in high glucose medium (Figure 2a). No
apparent increment of ROS generation, however, was
observed in RPTs from Tg mice stimulated by Ang II or
high-glucose. Similarly, Agt mRNA levels were also increased
significantly in RPTs of WT mice incubated in high glucose or
in normal glucose plus Ang II for 24 h (Figure 2b). The
stimulatory effect of high glucose and Ang II on Agt mRNA
expression was abolished in RPTs of Tg mice. Western
blotting confirmed the effect of high glucose and Ang II on
Agt protein expression in RPTs of WT and Tg mice (Figure
2c). These results indicate that ROS may mediate, at least in
part, the effect of high glucose and Ang II on Agt mRNA and
protein expression in RPTs in vivo.
Kidney hypertrophy and albuminuria in diabetic mice
Figure 3 presents the physical and biochemical data on both
non-diabetic and diabetic WT and Tg mice. Diabetes in both
WT and Tg mice as induced by streptozotocin (STZ) led to
blood glucose elevation (Figure 3a), increases in 24-h urinary
albumin excretion (Figure 3b), and higher kidney weight/
body weight ratios (Figure 3c) compared with non-diabetic
animals. Normalization of blood glucose by insulin reversed
these parameters to non-diabetic levels.
Next, we investigated STZ-induced structural damage to
the kidney by standard light microscopy. Glomeruli and RPTs
appeared to be hypertrophic in both diabetic WT and Tg
animals compared with their non-diabetic controls (Figure 4).
Insulin treatment reversed the glomerular and RPT hyper-
trophy in diabetic WT and Tg mice. Furthermore, an increase
of cellular edema and detachment and loss of RPTC brush-
border were evident in diabetic WT kidneys. These
pathological changes appeared to be attenuated in diabetic
Tg kidneys. Insulin treatment ameliorated these pathological
changes in both diabetic WT and Tg kidneys.
rCAT overexpression prevents increases in Agt and PAI-1
mRNA expression in diabetic RPTs
RT-quantitative PCR (RT-qPCR) analysis revealed that Agt
mRNA expression is significantly increased (at least four- to
five-fold) in RPTs of diabetic WT mice compared with non-
diabetic WT mice (Figure 5a). Insulin significantly inhibited
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Figure 2 | Effect of high glucose or Ang II on ROS production and
Agt mRNA and protein expression in mRPTs ex vivo. mRPTs from
male WT or Tg mice were incubated in 5 mM D-glucose plus 20 mM
D-mannitol (N.B.: D-mannitol was used to normalize the osmolarity as
in 25 mM D-glucose medium) or 25 mM D-glucose serum-free
Dulbecco’s modified eagle’s medium in the absence or presence of
Ang II (109 M) for (a) 5 h or (b) 24 h. (a) ROS generation was assessed
after 10 min incubation in Krebs buffer and expressed as RLU. (b) Agt
and b-actin mRNA expression. The relative density of Agt mRNA
bands was normalized with those of b-actin mRNA. Agt mRNA level in
mRPTs incubated in 5 mM D-glucose Dulbecco’s modified eagle’s
medium was considered as control (100%). Each point represents the
mean7s.d. of three independent experiments performed in
duplicate (*Po0.05, **Po0.01; NS, not significant). (c) Western
blotting of Agt and b-actin protein expression in mRPTs incubated in
5 mM D-glucose Dulbecco’s modified eagle’s medium with or with
Ang II or in 25 mM D-glucose Dulbecco’s modified eagle’s medium.
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RPT Agt mRNA expression in diabetic WT mice but could
not normalize to levels as in non-diabetic WT mice. Similarly,
Agt protein expression (immunostaining) was increased in
diabetic WT mouse kidneys (Figure 5b–g). Insulin treatment
attenuated but could not completely prevented RPT Agt
expression in diabetic WT mice. In contrast, RPT Agt
expression was not increased in diabetic Tg mouse kidneys
with or without insulin treatment (Figure 5b–g). Non-
immune normal rabbit serum displayed no immunostaining
for ANG in both non-Tg and Tg mouse kidneys (data not
shown).
Semiquantitative estimation of the number of Agt-positive
stained tubules confirmed a three-fold increase of Agt-
positive tubules in diabetic WT mice compared with non-
diabetic WT mice (Figure 5h). Treatment with insulin
attenuated but could not completely normalize the number
of Agt-positive tubules to levels as in non-diabetics. In
contrast, there was no apparent increase of Agt-positive
stained tubules in diabetic Tg mice with or without insulin
treatment compared with non-diabetic Tg mice.
Conventional RT-PCR analysis also showed that plasmi-
nogen activator inhibition-1 (PAI-1) and Agt mRNA (Figure
6a and b, left panel) levels in RPTs were significantly
increased in diabetic WT mice compared with non-diabetic
WT mice. rCAT overexpression prevented the increment of
PAI-1 and Agt mRNA in RPTs of diabetic Tg mice (Figure 6a
and b, right panel). Insulin treatment was not effective,
however, in normalizing PAI-1 and Agt mRNA levels in
diabetic WT mouse RPTs (Figure 6a and b, left panel). These
studies confirm that hyperglycemia evokes ROS generation
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Figure 3 | Blood glucose, urinary albumin, and kidney/body
weight ratio in male WT and Tg mice after 2 weeks of
STZ-induced diabetes with or without normalization with insulin.
(a) Blood glucose in WT (empty bars) and Tg (solid bars) mice.
(b) twenty four-hour total urinary albumin of WT and Tg mice.
(c) Kidney-to-body weight ratio. All data are expressed as
means7s.d., n¼ 12 (*Po0.05, **Po0.01; NS, not significant).
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Figure 4 | PAS staining of male WT and Tg mouse kidneys
2 weeks after STZ-induction of diabetes with or without
normalization with insulin. (a) Non-diabetic control littermate,
(b) STZ-induced diabetic control littermate, (c) STZ-induced diabetic
control littermateþ insulin, (d) non-diabetic transgenic mouse,
(e) STZ-induced diabetic transgenic animal, and (f) STZ-induced
transgenic animalþ insulin. Original magnification  600.
Kidney International (2007) 71, 912–923 915
M-L Brezniceanu et al.: Intrarenal catalase expression in transgenic mice o r i g i n a l a r t i c l e
(as implied by increased PAI-1 mRNA expression) and
subsequently upregulates Agt mRNA expression in diabetic
mice RPTs.
rCAT overexpression attenuates proapoptotic gene
expression in diabetic RPTs
Figure 7 shows that the expression of p53 and Bax mRNA was
significantly elevated in RPTs of diabetic WT compared with
non-diabetic WT mice (Figure 7a and b, left panel). Increases
in p53 and Bax mRNA levels were prevented in Tg mice
overexpressing rCAT in their RPTs (Figure 7a and b, right
panel). Insulin treatment was effective, however, in dimin-
ishing Bax mRNA but not p53 mRNA levels in diabetic WT
mouse RPTs to controls.
To investigate whether the caspase-3 cascade was activated
in diabetic RPTs, caspase-3 mRNA and activity were analyzed
by RT-PCR and activity assay, respectively. Figure 8a reveals
that caspase-3 mRNA expression was significantly increased in
RPTs of diabetic WT compared with non-diabetic WT mice.
Insulin treatment normalized the caspase-3 mRNA level.
Furthermore, a significant increase in caspase-3 activity was
observed in RPTs of diabetic WT mice (Figure 8b). In
contrast, there were no apparent increases in caspase-3 mRNA
levels and activity in diabetic Tg mice (Figure 8a and b).
rCAT overexpression prevents apoptosis in diabetic RPTs
Active caspase-3 and apoptosis in mouse kidneys were
examined by immunohistochemistry and TUNEL assay,
respectively. Active caspase-3 was present in RPTCs as well
as in distal tubules (DT) of diabetic mice (Figure 9b) but not
in non-diabetic WT and Tg mice (Figure 9a and c) and
diabetic Tg mice (Figure 9d).
Furthermore, TUNEL assay revealed positively stained
nuclei in RPTCs as well as in distal tubules of diabetic WT
mice (Figure 10b and c) but not in RPTCs of non-diabetic
WT and Tg mice (Figure 10a and d) and diabetic Tg mice
(Figure 10e and f). These data demonstrate that apoptosis is
clearly induced in RPTs and DT of diabetic mice and that
CAT overexpression prevents RPTC apoptosis in diabetes.
DISCUSSION
We report here that rCAT overexpression in RPTs of Tg mice
prevents ROS generation, Agt and proapoptotic gene
expression as well as RPT apoptosis in diabetes, indicating
occurrence of oxidative stress in mouse RPTs during early
phases of diabetes. Consistently, upregulation of CAT reverses
oxidative stress and RPT apoptosis in vivo.
To demonstrate that the antioxidant enzyme CAT can
prevent ROS generation and attenuate kidney injury in
diabetic mouse RPTs, Tg mice overexpressing rCAT specifi-
cally in their RPTs were generated. Tg line 688 showed that
the transgene was highly expressed in male kidneys with or
without exogenous testosterone induction but was not
expressed in other tissues. Protein expression and activity
of the transgene was confirmed by respective Western
blotting and activity assay in isolated mouse RPTs. CAT
activity was at least three- to four-fold higher in RPTs of Tg
compared WT. Thus, these findings are consistent with our
previous report as well as others that KAP2 directs the
transgene expression in RPTCs.36,37
High glucose levels evoke ROS generation and enhance
Agt gene expression in rat and mouse RPTC lines in
vitro.34,35,38,39 Consistently, high glucose and Ang II evoked
ROS generation in RPTs of WT mice ex vivo. Most
importantly, there was no apparent increase of ROS
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Figure 5 | RT-qPCR and immunostaining of respective mAgt
mRNA and protein expression in RPTs of non-diabetic and
disbetic WT and Tg mice with or without insulin
supplementation. (a) After 2 weeks of diabetes, RPTs from WT and
Tg mice were isolated and assayed for mAgt mRNA levels by
RT-qPCR. The relative densities of mAgt mRNA were normalized with
the b-actin mRNA. Agt mRNA levels in WT animals were considered as
100%. Each point represents the mean7s.d. of 12 animals (**Po0.01,
***Po0.005). (b–g) Representative staining of Agt in male
non-diabetic and diabetic WT and Tg mouse kidneys after 2 weeks of
STZ-induced diabetes. Stain was performed using rabbit anti-rAgt
polyclonal antibodies. (b) Non-diabetic control WT mouse kidney.
(c) Diabetic control WT mouse kidney. (d) STZ-induced diabetic
control WT mouse kidneyþ insulin. (e) Non-diabetic Tg mouse
kidney. (f) STZ-induced diabetic Tg mouse kidney. (g) STZ-induced
diabetic Tg mouse kidneyþ insulin. The arrow heads indicate the
immunoreactive Agt in the tubules. Original magnification  200.
(h) Bar graph showing quantitative analysis of Agt-positive stained
tubules from male WT and Tg mouse kidneys after 2 weeks of
STZ-induced diabetes with or without treatment with insulin. All data
are expressed as means7s.d., n¼ 6 (*Po0.05, NS, not significant).
WT (empty bars) and Tg (solid bars) mice.
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generation in RPTs of Tg male mice when stimulated with
high glucose or Ang II. Furthermore, Agt mRNA levels were
significantly elevated in WT RPTs incubated in high glucose
or stimulated with Ang II, compared with RPTs incubated in
normal glucose medium. rCAT overexpression completely
abolished the increment of Agt mRNA in Tg RPTs stimulated
by high glucose and Ang II. Western blotting confirmed the
high glucose and Ang II upregulation of Agt protein
expression in RPTs of WT but not Tg. Taken together, these
observations suggest that rCAT overexpression in Tg RPTs is
effective in preventing ROS generation stimulated by high
glucose or Ang II and consequently abrogates Agt gene
expression.
STZ is effective in inducing diabetes, with renal injury
including renal hyperperfusion, albuminuria, glomerular and
RPT hypertrophy, glomerular basement thickening and
extracellular matrix protein gene expression in the
mouse.40,41 After 2 weeks of induction with STZ, all mice
exhibited increased blood glucose, increased kidney to body
weight ratio and proteinuria (a marker of kidney injury42).
These parameters were not ameliorated by rCAT over-
expression in RPTs of Tg mice, but these were completely
abrogated by insulin treatment. Thus, our data indicate that
rCAT overexpression in RPTCs alone was not sufficient to
prevent the physiological changes seen in the diabetic kidney.
We would suggest that the increased kidney/body weight
ratio and albuminuria were because of the diabetic state per se
and not to a nephrotoxic effect of STZ, as normalization of
blood glucose by insulin reversed these parameters. Indeed,
periodic acid schiff (PAS) staining of kidney sections from
non-diabetic and diabetic mice (both WT and Tg mice)
revealed structural damage to the kidney in STZ-treated
NS1400
1200
1000
800
600
400
200
0 0
700
600
500
400
300
200
100
0
700
600
500
400
300
200
100
0
W
T
Ca
tala
se 
(S)
+ST
Z
Ca
tala
se 
(S)
+ST
Z+I
nsu
lin
Ca
tala
se 
(S)
W
T+
ST
Z
W
T+
ST
Z+
Ins
ulin
W
T
Ca
tala
se 
(S)
+ST
Z
Ca
tala
se 
(S)
+ST
Z+I
nsu
lin
Ca
tala
se 
(S)
W
T+
ST
Z
W
T+
ST
Z+
Ins
ulin
1400
1200
1000
800
600
400
200
Agt
N.S.
N.S.
NS
***
NS
NS
NS NS
N.S.
-actin
-actin
Agt
-actin
PAI-1PAI-1
%
 o
f P
AI
-1
 m
R
N
A 
ex
pr
es
sio
n,
ra
tio
 to
 
-
a
ct
in
 (%
 of
 co
ntr
ol)
%
 o
f P
AI
-1
 m
R
N
A 
ex
pr
es
sio
n,
ra
tio
 to
 
-
a
ct
in
 (%
 of
 co
ntr
ol)
%
 o
f A
gt
 m
RN
A 
ex
pr
es
sio
n,
ra
tio
 to
 
-
a
ct
in
 (%
 of
 co
ntr
ol)
%
 o
f A
gt
 m
RN
A 
ex
pr
es
sio
n,
ra
tio
 to
 
-
a
ct
in
 (%
 of
 co
ntr
ol)
-actin
**
*
a
b
Figure 6 | RT-PCR assays of PAI-1 and Agt mRNA expression in RPTs of non-diabetic and diabetic WT and Tg mice with or without
insulin supplementation. After 2 weeks of diabetes, RPTs from WT and Tg mice were isolated and assayed for (a) PAI-1 mRNA or (b) Agt mRNA
levels by RT-PCR. The relative densities of PAI-1 and Agt mRNA were normalized with the b-actin mRNA. PAI-1 mRNA levels in WT animals were
considered as 100%. Each point represents the mean7s.d. of 12 animals (*Po0.05, **Po0.01, ***Po0.005; NS, not significant).
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animals, including glomerular and tubular hypertrophy, loss
of brush border, cellular edema and detachment. These
pathological changes were ameliorated with insulin treatment
in both WT and Tg kidneys.
PAI-1 is overexpressed in pathological conditions asso-
ciated with renal fibrosis, including diabetic nephro-
pathy.43–45 ROS mediate high glucose-induced up-regulation
of PAI-1 expression in cultured mesangial cells and diabetic
glomeruli.46,47 Thus, PAI-1 is a useful marker of ROS-
inducible gene. PAI-1 and Agt mRNA expression were
increased in RPTs of diabetic WT mice. Furthermore, the
increase of PAI-1 and Agt mRNA was abolished in RPTs of
male Tg mice, providing further evidence that ROS mediate
the effect of high glucose-induced expression of Agt gene and
RAS activation.
It is noteworthy that insulin treatment did not completely
normalize Agt protein as well as PAI-1, ANG and p53 mRNA
levels in diabetic WT mice. These data are consistent with our
previous observations that prolonged exposure to high
glucose evokes insulin resistance on inhibition of Agt mRNA
expression in RPTCs,35 and hyperglycemia induces insulin
resistance on Agt gene expression in diabetic rat RPTCs.48
Although the exact molecular mechanism(s) of high-glucose
induction of insulin resistance remains uncertain, persistent
ROS generation might be involved.35
High glucose is a potent inducer of apoptosis in RPTCs
via ROS generation and activation of multiple caspases.28–33
Consistent with these findings, we detected significantly
enhanced expression of the proapoptotic gene p53, Bax, and
caspase-3 mRNA in RPTs of WT diabetic mice, but not in
RPTs of Tg diabetic mice, suggesting that ROS generation
mediates, at least in part, by the induction of proapoptotic
genes in WT diabetic mice. Active caspase-3 protein
expression is found in RPTs and other renal cells (e.g., DT)
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of diabetic WT mice, but not in RPTs of Tg diabetic mice.
These observations hint that apoptosis is actually induced in
the RPTCs of diabetic mice and that CAT overexpression may
prevent it. Indeed, the TUNEL assay results revealed increases
in the number of positively stained cells in the RPTs of WT
diabetic mice compared with RPTs in non-diabetic WT mice.
Additionally, the number of positively stained cells was
significantly reduced in Tg diabetic mice.
In summary, our data indicate an important role for ROS
in the pathogenesis of nephropathy in diabetes. CAT plays a
relevant role in modulating diabetes-induced oxidative stress,
proapoptotic gene expression, and apoptosis in RPTs in vivo.
Selective activation of this enzyme may provide an alternative
approach in preventing or reversing pathophysiological
manifestations of diabetic nephropathy.
MATERIALS AND METHODS
Reagents
D(þ )-glucose, D-mannitol, human Ang II, rabbit polyclonal
antibodies against bovine CAT, and monoclonal antibodies against
b-actin were purchased from Sigma-Aldrich Canada Ltd (Oakville,
ON, Canada). A rabbit polyclonal antibody against rat Agt was
generated in our lab (JSDC) and reported previously.49 The anti-
rAgt antibody cross-reacts with rat and mouse Agt but has no cross-
reactivity with murine pituitary hormones and albumin as well as
plasma proteins from dog, cat, hamster or human.49 rCAT cDNA
was a gift from Dr Paul E Epstein (University of Louisville,
Louisville, KY, USA). The pKAP2 plasmid containing the KAP
promoter responsive to testosterone stimulation was obtained from
Dr Curt D Sigmund (University of Iowa, Iowa, IA, USA) and has
been described elsewhere.36 Placebo pellets or pellets containing
5 mg testosterone with a 21-day release schedule (Cat. no. A-121)
were purchased from Innovative Research of America (Sarasota, FL,
USA). Oligonucleotides were synthesized by InVitrogen Inc.
(Burlington, ON, Canada). Restriction and modifying enzymes
were purchased from either InVitrogen Inc., La Roche Biochemicals
(Dorval, QC, Canada) or Amersham-Pharmacia Biotech Inc. (Baie
d’Urfe´, QC, Canada).
Generation of KAP2-rCAT Tg mice
Tg mice overexpressing rCAT in their RPTCs were generated
according to the procedures we described previously for Tg mice
overexpressing rAgt in RPTCs.37 Briefly, cDNA encoding full-length
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rCAT fused with HA-tag and terminating codon at the 30 end (NotI
site flanked at both 50- and 30-terminali) was inserted into pKAP2
plasmid at the NotI site of exon II of human angiotensinogen (hAgt)
gene. The isolated KAP2-rCAT transgene was then microinjected
into one-cell fertilized mouse embryos using a standard procedure.37
Five founder mice were identified. The positive Tg founders were
then crossed with WT C57Bl6 mice for F1 generation. Breeding was
continued until homozygous F3 and F4 Tg mice were obtained.
The Tg mice used in our experiments were males, aged 10–14
weeks at the time of data collection, unless otherwise noted. Non-Tg
(WT) littermates served as controls. All animals received standard
mouse chow and water ad libitum. Animal care and procedures were
approved by the Animal Care Committee of the CHUM.
Analysis of transgene expression
Placebo pellets or pellets containing 5 mg testosterone with a 21-day
release schedule were implanted surgically in WT and Tg mice in
order to see whether exogenous testosterone further increased
expression in males and to induce it in females.37 Two weeks after
testosterone implantation, the animals were killed and various
tissues were harvested and snap-frozen on dry ice. Total RNA was
isolated from various tissues and subjected to RT-PCR analysis.37
The rCAT sense primer50 and the HA antisense primer (Table 1),
b-actin forward primer and reverse primer51 (Table 1) were used for
PCR. rCAT-HA mRNA levels were normalized by corresponding
b-actin mRNA levels.
Morphological studies and immunohistochemical staining
Kidneys were collected in Tissue-Tek cassettes (VWR Canlab,
Montreal, QC, Canada), dipped immediately in ice-cold formalde-
hyde (10% in phosphate-buffered saline), and fixed for 24 h at 41C.
The cassettes were then processed by the CHUM Pathology
Department. Tissue sections (4–5 specimen per group) were stained
with PAS and analyzed visually under a light microscope by an
observer unaware of the treatments.
Immunohistochemical staining was performed via a standard
avidin–biotin–peroxidase complex method (ABC Staining System,
Santa Cruz Biotechnologies, Santa Cruz, CA, USA).37 Renal sections
were incubated with non-immune serum (1:100 dilution) or
primary anti-rAgt (1:100 dilution)49 or anti-CAT polyclonal anti-
body (1:500 dilution) or anti-active alpha (a) caspase-3 polyclonal
antibody (Chemicon, Temecula, CA, USA) (1:50 dilution) for 1 h at
room temperature. Then, a biotinylated secondary antibody was
added, followed by the addition of preformed ABC reagent supplied
by kit. Agt, CAT, and a-active caspase-3 proteins were visualized by
color development with 3, 30-diaminobenzidine tetrahydrochloride
and counterstained with hematoxylin.
The percentage of tubules that stained positive for Agt in kidneys
of WT and Tg mice was estimated semiquantitatively. Briefly, 6–10
fields per animal were randomly selected from group of animals.
Then the total number of tubules containing Agt-stained cells was
divided from the total number of tubules counted and multiplied by
100 to derive the percentage of Agt-positive stained tubules.
Induction of diabetes
Male WT and Tg mice at 10–12 weeks of age each were divided into
three subgroups (12 mice per group): (1) vehicle-injected control
group. These animals were injected intraperitoneally (i.p.) with
10 mM sodium citrate buffer, pH 4.0, in 0.9% saline. (2) STZ-
induced diabetic group. After overnight fasting, these animals were
administered 150 mg/kg of STZ dissolved in 10 mM sodium citrate
buffer, pH 4.0, in 0.9% saline, i.p. Forty-eight hours after STZ
a
c
b
d
-Active caspase-3α
Figure 9 | Immunohistochemical staining of a-active caspase-3 in male non-diabetic and diabetic WT and Tg mouse kidneys after
2 weeks of STZ induction by employing rabbit anti-a-active caspase-3 polyclonal antibodies. (a) Non-diabetic control WT mouse kidney.
(b) Diabetic control WT mouse kidney. (c) Non-diabetic Tg mouse kidney. (d) Diabetic Tg mouse kidney. The arrows indicated the
immunoreactive a-active caspase-3. Original magnification  200.
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administration, blood was assayed for glucose levels with a Side-Kick
Glucose Analyzer (Model 1500, Interscience, ON, Canada). Only
mice with blood glucose 4400 mg/dl or 420 mM were included in
the study. (3) Insulin-treated diabetic group. Confirmed STZ-
induced diabetic mice received a subcutaneous insulin implant,
Linplant (Linshin, Scarborough, ON, Canada) at 24 h after STZ
administration to maintain euglycemia. After 2 weeks of diabetes
with or without insulin implant, the animals were killed with CO2.
Twenty-four hours before killing, animals were housed individually
in metabolic cages. Urine samples were collected and assayed for
glucose and ketone levels (Keto-Diastix, Bayer Inc., Healthcare
Division, Toronto, ON, Canada) and albuminuria (ELISA, Albuwell,
Exocell, Philadelphia, PA, USA). Kidneys were removed immediately
after killing. Kidneys from the left side were sectioned in half
longitudinally and one-half was taken for pathology studies. The
remaining half of the left kidney and the right kidney from each
animal were pooled for proximal tubule isolation by Percoll gradient
with slight modifications.48,38
Aliquots of freshly isolated mRPTs from individual mice were
used immediately for protein extraction or total RNA isolation or
assay of CAT and caspase-3 activity. The remaining mRPTs were
then pooled, suspended in serum-free culture medium,38 incubated
at 371C in the absence or presence of Ang II (109 M) or in 25 mM D-
glucose medium for 16 h. At the end of the incubation period,
mRPTs were harvested and assayed for ROS generation and gene
expression.
Western blot analysis
Western blot analysis was performed according to the method
described previously.37,48,38 The membrane was first blotted
with rabbit anti-Agt or anti-CAT, and then reblotted with anti-
b-actin monoclonal antibodies and chemiluminescent developing
reagent.
CAT activity assay
CAT activity in mRPTs was determined after decomposition of
10 mM H2O2 in 50 mM phosphate buffer, pH 7.0, by monitoring the
linear decrease of absorbance at 240 nm for 30 s as described by
Aebi.52 The amounts of H2O2 decomposed by CAT were calculated
with the millimolar extinction coefficient of H2O2 (h240¼ 0.0436).
CAT activity was defined as mmol of H2O2 consumed/min/mg of
tissue protein at 10 mM H2O2.
a
b
c f
e
d
Figure 10 | Apoptosis in male non-diabetic and diabetic WT and Tg mouse kidneys after 2 weeks of STZ induction analyzed by
terminal transferase-mediated deoxyuridine triphosphate (dUTP) nick end-labeling staining. (a) Non-diabetic control WT mouse kidney,
original magnification  10. (b) Diabetic control WT mouse kidney, magnification  10. (c) Diabetic control WT mouse kidney, original
magnification  40. (d) Non-diabetic Tg mouse kidney, original magnification  10. (e) Diabetic Tg mouse kidney, magnification  10.
(f) Diabetic Tg mouse kidney, original magnification  400. The arrows indicated the apoptotic cells. GL, glomerulus; PT, proximal tubule; DT,
distal tubule. Original magnification  200.
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ROS generation
ROS production was monitored by the lucigenin method with
minor modifications.34,38 ROS generated in mRPTs were normalized
with protein concentration and expressed as relative light units per
mg protein.
Conventional RT-PCR and real time RT-qPCR assays for
gene expression
Total RNA was used in conventional RT-PCR to quantify the
amount of PAI-1, Agt, p53, Bax and caspase-3 mRNA expressed
in mRPTs according to previously described protocols.34,35,38
The forward and reverse primers corresponding to PAI-1,53 Agt,54
p53,55 Bax,56 caspase-3,57 and b-actin cDNA51 in the RT-PCR
assays are described in Table 1. PAI-1, Agt, p53, Bax, and caspase-3
mRNA levels were normalized by corresponding b-actin mRNA
levels.
The total RNA was also used for RT-qPCR for mouse Agt as
described previously.58 The primers for mouse Agt (NM_007428):
sense 50-ACA GAC ACC GAG ATG CTG TT-30 and antisense
50-CCA CGC TCT CTG GAT TTA TC-30 were used in RT-qPCR.
Caspase-3 activity assay
Caspase-3 activity was assayed on frozen (801C) mPTs using
caspase-3 assay kits (BD Bioscience Pharmingen, Mississauga, ON,
Canada).
Terminal transferase-mediated deoxyuridine triphosphate
(dUTP) nick end-labeling assay
Kidneys from WT and Tg mice were removed immediately after
killing. Formaldehyde (10%)-fixed, paraffin-embedded kidney
sections (5-mm thick) were deparaffinized in xylene and rehydrated.
Apoptosis was quantified with a TUNEL kit (La Roche Biochem-
icals) according to the supplier’s instructions.
Statistical analysis
Data were expressed as means7s.d. Student’s t-test was used
initially to analyze the statistical significance between experimental
groups. Then, the data were analyzed by one-way analysis of
variance and the Bonferroni test. Po0.05 values were considered to
be statistically significant.
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